Introduction Pancreatic ductal adenocarcinoma (PDA), or pancreatic cancer, is a devastating exogenous pancreatic disease that ranks the fourth leading cause of cancer mortality and is projected to be the second leading cause of death by 2030 in the United States (Rahib et al., 2014
When I myself get sick, I find that I recover much more quickly if I let the fever do its job
Kennedy concludes, microdosing GLP-1s can be a practical, cost-effective alternative for patients who either cant tolerate full doses or are looking for a gentler on-ramp to treatment
This discussion forms part of our upcoming Clinical Services Ones to Watch report, shining a spotlight on some of the leading companies making an impact and driving innovation, which were excited to share soon
Your provider will build a protocol based on your goals, your response to treatment, and your broader health picture